(Q79204181)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14576816%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

Oncogenes, tumor suppressors and p52 NF-kappaB (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14576816%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Oncogenes, tumor suppressors and p52 NF-κB (English)

1 reference

DOI

https://api.crossref.org/works/10.1038/SJ.ONC.1207139

24 March 2024

1 reference

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1207139

24 March 2024

author name string

Neil D. Perkins

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14576816

24 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14576816

24 March 2024

publication date

1 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14576816%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

23 October 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14576816

full work available at URL

24 March 2024

https://www.nature.com/articles/1207139.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14576816

https://www.nature.com/articles/1207139.pdf

24 March 2024

file format

Portable Document Format

1 reference

DOI

https://api.crossref.org/works/10.1038/SJ.ONC.1207139

https://www.nature.com/articles/1207139

24 March 2024

1 reference

DOI

https://api.crossref.org/works/10.1038/SJ.ONC.1207139

24 March 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14576816%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14576816%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14576816%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

7553-7556

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14576816%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.onc.1207139

20 December 2019

exact match

0 references

cites work

Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207139

7 January 2021

A novel mitogen-inducible gene product related to p50/p105-NF-kappa B participates in transactivation through a kappa B site

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207139

7 January 2021

The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207139

7 January 2021

Increased expression of p50-NF-kappaB and constitutive activation of NF-kappaB transcription factors during mouse skin carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207139

7 January 2021

Epstein-barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-kappaB.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207139

7 January 2021

IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207139

7 January 2021

Rearranged NFKB-2 genes in lymphoid neoplasms code for constitutively active nuclear transactivators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207139

7 January 2021

Constitutive expression of lymphoma-associated NFKB-2/Lyt-10 proteins is tumorigenic in murine fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207139

7 January 2021

Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207139

7 January 2021

CD40 regulates the processing of NF-kappaB2 p100 to p52

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207139

7 January 2021

The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207139

7 January 2021

Dimerization of NF-KB2 with RelA(p65) regulates DNA binding, transcriptional activation, and inhibition by an I kappa B-alpha (MAD-3)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207139

7 January 2021

Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappa B

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207139

7 January 2021

Nuclear transcription factor-kappaB as a target for cancer drug development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207139

7 January 2021

The generation of nfkb2 p52: mechanism and efficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207139

7 January 2021

Gastric hyperplasia and increased proliferative responses of lymphocytes in mice lacking the COOH-terminal ankyrin domain of NF-kappaB2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207139

7 January 2021

NF-kappa B is required for H-ras oncogene induced abnormal cell proliferation and tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207139

7 January 2021

BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207139

7 January 2021

Transcriptional regulation of NF-kappa B2: evidence for kappa B-mediated positive and negative autoregulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207139

7 January 2021

Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207139

7 January 2021

BCL3 rearrangement and t(14;19)(q32;q13) in lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207139

7 January 2021

Lymphotoxin and lipopolysaccharide induce NF-kappaB-p52 generation by a co-translational mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207139

7 January 2021

The role of Rel/NF-kappa B proteins in viral oncogenesis and the regulation of viral transcription

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207139

7 January 2021

Lymphotoxin beta receptor induces sequential activation of distinct NF-kappa B factors via separate signaling pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207139

7 January 2021

An inducible transcription factor activates expression of human immunodeficiency virus in T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207139

7 January 2021

B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207139

7 January 2021

The bcl-3 proto-oncogene encodes a nuclear I kappa B-like molecule that preferentially interacts with NF-kappa B p50 and p52 in a phosphorylation-dependent manner

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207139

7 January 2021

The Rel/NF-kappa B family: friend and foe.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207139

7 January 2021

An interaction between the DNA-binding domains of RelA(p65) and Sp1 mediates human immunodeficiency virus gene activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207139

7 January 2021

A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207139

7 January 2021

p53 represses cyclin D1 transcription through down regulation of Bcl-3 and inducing increased association of the p52 NF-kappaB subunit with histone deacetylase 1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207139

7 January 2021

Modulation of NF-kappaB activity by exchange of dimers.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207139

7 January 2021

Cloning of an NF-kappa B subunit which stimulates HIV transcription in synergy with p65

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207139

7 January 2021

Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207139

7 January 2021

NF- kappa B2/p100 induces Bcl-2 expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207139

7 January 2021

NF-kappa B2 p100 is a pro-apoptotic protein with anti-oncogenic function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207139

7 January 2021

Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207139

7 January 2021

The putative oncoprotein Bcl-3 induces cyclin D1 to stimulate G(1) transition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207139

7 January 2021

Retroviral oncoprotein Tax induces processing of NF-kappaB2/p100 in T cells: evidence for the involvement of IKKalpha

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207139

7 January 2021